Lympharma

Lympharma was a biotechnology company focused on the development of specialized drug delivery systems targeting the lymphatic system. Based in Israel, the company utilized a proprietary liposomal platform designed to enhance the transport of therapeutic agents through lymphatic vessels, which is critical for treating metastatic cancer and various autoimmune disorders. Their technology aimed to improve the bioavailability and efficacy of drugs that are otherwise poorly absorbed or rapidly cleared from the systemic circulation. Although the company made significant strides in pre-clinical research, it is currently considered inactive.